Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
9.64
-0.07 (-0.72%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $141.96 million as of October 2, 2026. Its market cap has decreased by -65.57% in one year.
Market Cap
141.96M
Enterprise Value
46.25M
1-Year Change
-65.57%
Ranking
Category
Stock Price
$9.64
ChartMarket Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $141.96M, an increase of 14.67%. That is a compound annual growth rate of 4.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 141.96M | 88.19% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 154.03M |
| PepGen | 153.06M |
| Jyong Biotech | 150.69M |
| Acumen Pharmaceuticals | 149.70M |
| Codexis | 148.93M |
| Tiziana Life Sciences | 147.41M |
| Innate Pharma | 142.42M |
| Outlook Therapeutics | 139.98M |